Literature DB >> 28590140

A case series comparison of semantically focused vs. phonologically focused cued naming treatment in aphasia.

Yael Neumann1.   

Abstract

There is a lack of clarity in the field regarding how to best predict which naming treatment will be most beneficial for a particular individual with aphasia. The purpose of this study was to elucidate whether or not semantic or phonological therapy differentially impacts on outcomes for people with a range of different aphasic profiles when given both therapies. A single-participant design, with multiple repeated baselines for naming, replicated across four participants, was used. Participants were provided with a counterbalanced order of Semantic Feature Analysis (SFA) and Phonological Components Analysis (PCA) treatment. Findings demonstrated differential effects across participants. This seemed to be influenced by factors such as severity of anomia, order of treatment presentation, and capacity limits. Clinical implications of these findings highlight the importance of expanding our picture of a participant's behaviours to consider what other important factors can inform intervention decisions.

Entities:  

Keywords:  Aphasia; Phonological Components Analysis; Semantic Feature Analysis; naming treatment

Mesh:

Year:  2017        PMID: 28590140     DOI: 10.1080/02699206.2017.1326166

Source DB:  PubMed          Journal:  Clin Linguist Phon        ISSN: 0269-9206            Impact factor:   1.346


  2 in total

1.  Individualized response to semantic versus phonological aphasia therapies in stroke.

Authors:  Sigfus Kristinsson; Alexandra Basilakos; Jordan Elm; Leigh Ann Spell; Leonardo Bonilha; Chris Rorden; Dirk B den Ouden; Christy Cassarly; Souvik Sen; Argye Hillis; Gregory Hickok; Julius Fridriksson
Journal:  Brain Commun       Date:  2021-08-05

2.  French Phonological Component Analysis and aphasia recovery: A bilingual perspective on behavioral and structural data.

Authors:  Michèle Masson-Trottier; Tanya Dash; Pierre Berroir; Ana Inés Ansaldo
Journal:  Front Hum Neurosci       Date:  2022-09-22       Impact factor: 3.473

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.